ZEB1 controls a lineage-specific transcriptional program essential for melanoma cell state transitions

Archive ouverte

Durand, Simon | Tang, Yaqi | Pommier, Roxane, M | Benboubker, Valentin | Grimont, Maxime | Boivin, Felix | Barbollat-Boutrand, Laetitia | Cumunel, Eric | Dupeuble, Florian | Eberhardt, Anaïs | Plaschka, Maud | Dalle, Stéphane | Caramel, Julie

Edité par CCSD ; Nature Publishing Group [1987-....] -

International audience. Cell plasticity sustains intra-tumor heterogeneity and treatment resistance in melanoma. Deciphering the transcriptional mechanisms governing reversible phenotypic transitions between proliferative/differentiated and invasive/stem-like states is required. Expression of the ZEB1 transcription factor is frequently activated in melanoma, where it fosters adaptive resistance to targeted therapies. Here, we performed a genome-wide characterization of ZEB1 transcriptional targets, by combining ChIP-sequencing and RNA-sequencing, upon phenotype switching in melanoma models. We identified and validated ZEB1 binding peaks in the promoter of key lineage-specific genes crucial for melanoma cell identity. Mechanistically, ZEB1 negatively regulates SOX10-MITF dependent proliferative/melanocytic programs and positively regulates AP-1 driven invasive and stem-like programs. Comparative analyses with breast carcinoma cells revealed lineage-specific ZEB1 binding, leading to the design of a more reliable melanoma-specific ZEB1 regulon. We then developed single-cell spatial multiplexed analyses to characterize melanoma cell states intra-tumoral heterogeneity in human melanoma samples. Combined with scRNA-Seq analyses, our findings confirmed increased ZEB1 expression in Neural-Crest-like cells and mesenchymal cells, underscoring its significance in vivo in both populations. Overall, our results define ZEB1 as a major transcriptional regulator of cell states transitions and provide a better understanding of lineage-specific transcriptional programs sustaining intra-tumor heterogeneity in melanoma

Suggestions

Du même auteur

ZEB1 transcription factor induces tumor cell PD-L1 expression in melanoma

Archive ouverte | Wirbel, Chloé | CCSD

International audience. Tumor cells can evade antitumor immune response by expressing the PD-L1 ligand, leading to the inhibition of PD-1expressing T lymphocytes. The mechanisms that regulate PD-L1 expression in can...

An in vivo avian model of human melanoma to perform rapid and robust preclinical studies

Archive ouverte | Jarrosson, Loraine | CCSD

International audience. Metastatic melanoma patients carrying a BRAFV600 mutation can be treated with a combination of BRAF and MEK inhibitors (BRAFi/MEKi), but innate and acquired resistance invariably occurs. Pred...

ZEB1 transcription factor promotes immune escape in melanoma

Archive ouverte | Plaschka, Maud | CCSD

International audience. Background The efficacy of immunotherapies in metastatic melanoma depends on a robust T cell infiltration. Oncogenic alterations of tumor cells have been associated to T cell exclusion. Ident...

Chargement des enrichissements...